Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China
· Delayed Price · Currency is CNY 14.68
+0.15 (1.03%)
Apr 29, 2026, 3:00 PM CST
SHA:688526 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 6,810 | 7,079 | 6,636 | 9,501 | 10,443 | 12,805 | Upgrade
|
| Market Cap Growth | -9.19% | 6.68% | -30.15% | -9.03% | -18.45% | -33.80% | Upgrade
|
| Enterprise Value | 4,434 | 5,366 | 5,635 | 8,216 | 9,522 | 10,651 | Upgrade
|
| Last Close Price | 14.68 | 15.26 | 13.91 | 19.40 | 21.14 | 25.76 | Upgrade
|
| PE Ratio | 16.31 | 16.91 | 17.36 | 24.00 | 25.50 | 22.44 | Upgrade
|
| Forward PE | 14.32 | 14.51 | 13.51 | 14.86 | 16.95 | 17.49 | Upgrade
|
| PS Ratio | 7.17 | 7.45 | 7.05 | 8.93 | 10.43 | 11.61 | Upgrade
|
| PB Ratio | 1.61 | 1.67 | 1.68 | 2.48 | 2.99 | 4.06 | Upgrade
|
| P/TBV Ratio | 1.63 | 1.70 | 1.71 | 2.52 | 3.04 | 4.14 | Upgrade
|
| P/FCF Ratio | 19.76 | 20.54 | 23.22 | 21.91 | 32.55 | 81.65 | Upgrade
|
| P/OCF Ratio | 14.54 | 15.11 | 16.90 | 17.66 | 24.65 | 24.10 | Upgrade
|
| EV/Sales Ratio | 4.67 | 5.65 | 5.98 | 7.72 | 9.51 | 9.66 | Upgrade
|
| EV/EBITDA Ratio | 9.15 | 11.11 | 13.32 | 17.46 | 19.83 | 16.68 | Upgrade
|
| EV/EBIT Ratio | 11.94 | 14.45 | 17.89 | 22.99 | 24.85 | 18.50 | Upgrade
|
| EV/FCF Ratio | 12.86 | 15.57 | 19.72 | 18.95 | 29.68 | 67.92 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.08 | 0.08 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.02 | 0.62 | 0.58 | 0.12 | Upgrade
|
| Debt / FCF Ratio | 0.02 | 0.02 | 0.02 | 0.68 | 0.87 | 0.50 | Upgrade
|
| Net Debt / Equity Ratio | -0.56 | -0.56 | -0.49 | -0.39 | -0.47 | -0.39 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.92 | -4.92 | -4.55 | -3.15 | -3.46 | -1.94 | Upgrade
|
| Net Debt / FCF Ratio | -6.90 | -6.90 | -6.74 | -3.42 | -5.18 | -7.89 | Upgrade
|
| Asset Turnover | 0.21 | 0.21 | 0.21 | 0.24 | 0.25 | 0.32 | Upgrade
|
| Inventory Turnover | 2.45 | 2.45 | 2.67 | 2.05 | 2.01 | 2.56 | Upgrade
|
| Quick Ratio | 5.88 | 5.88 | 4.95 | 2.85 | 3.82 | 3.34 | Upgrade
|
| Current Ratio | 6.40 | 6.40 | 5.34 | 3.38 | 4.11 | 3.58 | Upgrade
|
| Return on Equity (ROE) | 10.19% | 10.19% | 9.81% | 10.78% | 12.30% | 19.47% | Upgrade
|
| Return on Assets (ROA) | 5.00% | 5.00% | 4.29% | 4.93% | 5.90% | 10.53% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.88% | 16.57% | 12.55% | 14.74% | 17.90% | 39.80% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.60% | 8.60% | 7.80% | 9.10% | 10.20% | 17.80% | Upgrade
|
| Earnings Yield | 6.15% | 5.92% | 5.76% | 4.17% | 3.92% | 4.46% | Upgrade
|
| FCF Yield | 5.06% | 4.87% | 4.31% | 4.56% | 3.07% | 1.23% | Upgrade
|
| Dividend Yield | 4.40% | 4.19% | 3.09% | 2.22% | 0.90% | 0.74% | Upgrade
|
| Payout Ratio | 47.64% | 47.64% | 53.51% | 24.52% | 22.83% | 23.97% | Upgrade
|
| Buyback Yield / Dilution | 0.22% | 0.22% | -0.10% | -0.10% | -0.29% | -20.20% | Upgrade
|
| Total Shareholder Return | 4.60% | 4.42% | 2.99% | 2.12% | 0.61% | -19.46% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.